These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
293 related articles for article (PubMed ID: 8561143)
1. The prognostic value of preoperative serum levels of CEA and CA19-9 in patients with gastric cancer. Kodera Y; Yamamura Y; Torii A; Uesaka K; Hirai T; Yasui K; Morimoto T; Kato T; Kito T Am J Gastroenterol; 1996 Jan; 91(1):49-53. PubMed ID: 8561143 [TBL] [Abstract][Full Text] [Related]
2. The use of tumor markers as predictors of prognosis in gastric cancer. Mihmanli M; Dilege E; Demir U; Coskun H; Eroglu T; Uysalol MD Hepatogastroenterology; 2004; 51(59):1544-7. PubMed ID: 15362797 [TBL] [Abstract][Full Text] [Related]
3. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer. Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Lamerz R Anticancer Res; 2000; 20(6D):5195-8. PubMed ID: 11326694 [TBL] [Abstract][Full Text] [Related]
4. Prognostic value of preoperative serum levels of CEA, CA 19-9 and CA 72-4 in gastric carcinoma. Reiter W; Stieber P; Reuter C; Nagel D; Cramer C; Pahl H; Fateh-Moghadam A Anticancer Res; 1997; 17(4B):2903-6. PubMed ID: 9329559 [TBL] [Abstract][Full Text] [Related]
5. Comparison of serum CA72-4, CEA, TPA, CA19-9 and CA125 levels in gastric cancer patients and correlation with recurrence. Lai IR; Lee WJ; Huang MT; Lin HH Hepatogastroenterology; 2002; 49(46):1157-60. PubMed ID: 12143226 [TBL] [Abstract][Full Text] [Related]
6. [Usefulness of preoperative assay CEA and CA 19-9 in colorectal cancer patients]. Grotowski M; MaruszyĆski M; Piechota W Pol Merkur Lekarski; 2001 Dec; 11(66):476-9. PubMed ID: 11899841 [TBL] [Abstract][Full Text] [Related]
7. The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer. Ni XG; Bai XF; Mao YL; Shao YF; Wu JX; Shan Y; Wang CF; Wang J; Tian YT; Liu Q; Xu DK; Zhao P Eur J Surg Oncol; 2005 Mar; 31(2):164-9. PubMed ID: 15698733 [TBL] [Abstract][Full Text] [Related]
8. CA19-9 as the most significant prognostic indicator of metastatic colorectal cancer. Wang WS; Lin JK; Chiou TJ; Liu JH; Fan FS; Yen CC; Lin TC; Jiang JK; Yang SH; Wang HS; Chen PM Hepatogastroenterology; 2002; 49(43):160-4. PubMed ID: 11941943 [TBL] [Abstract][Full Text] [Related]
9. Is it reasonable to add preoperative serum level of CEA and CA19-9 to staging for colorectal cancer? Chen CC; Yang SH; Lin JK; Lin TC; Chen WS; Jiang JK; Wang HS; Chang SC J Surg Res; 2005 Apr; 124(2):169-74. PubMed ID: 15820244 [TBL] [Abstract][Full Text] [Related]
10. A comparison of tumour M2-PK with carcinoembryonic antigen and CA19-9 in patients undergoing liver resection for colorectal metastases. Kumar Y; Pinedo IR; Tapuria N; Zabron A; Davidson BR Eur J Gastroenterol Hepatol; 2008 Oct; 20(10):1006-11. PubMed ID: 18787469 [TBL] [Abstract][Full Text] [Related]
11. Prognostic value of preoperative CEA, CA 19-9, CA 72-4, and AFP levels in gastric cancer. Ucar E; Semerci E; Ustun H; Yetim T; Huzmeli C; Gullu M Adv Ther; 2008 Oct; 25(10):1075-84. PubMed ID: 18821070 [TBL] [Abstract][Full Text] [Related]
12. Increase in both CEA and CA19-9 in sera is an independent prognostic indicator in colorectal carcinoma. Nozoe T; Rikimaru T; Mori E; Okuyama T; Takahashi I J Surg Oncol; 2006 Aug; 94(2):132-7. PubMed ID: 16847905 [TBL] [Abstract][Full Text] [Related]
13. The clinical efficacy of CA 72-4 as serum marker for gastric cancer in comparison with CA19-9 and CEA. Kodama I; Koufuji K; Kawabata S; Tetsu S; Tsuji Y; Takeda J; Kakegawa T Int Surg; 1995; 80(1):45-8. PubMed ID: 7657491 [TBL] [Abstract][Full Text] [Related]
14. [Preoperative serum levels of CEA and CA19-9 in patients with gastric cancer]. Roviello F; Garosi L; Marrelli D; De Stefano A; Udhris C; Messano A; Pinto E Minerva Chir; 1996 Mar; 51(3):133-9. PubMed ID: 8684652 [TBL] [Abstract][Full Text] [Related]
15. Circulating level of hepatocyte growth factor as a useful tumor marker in patients with early-stage gastric carcinoma. Tanaka K; Miki C; Wakuda R; Kobayashi M; Tonouchi H; Kusunoki M Scand J Gastroenterol; 2004 Aug; 39(8):754-60. PubMed ID: 15513361 [TBL] [Abstract][Full Text] [Related]
16. Preoperative serum levels of CEA and CA 19-9 and their prognostic significance in colorectal carcinoma. Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Pahl H; Fateh-Moghadam A Anticancer Res; 1997; 17(4B):2935-8. PubMed ID: 9329568 [TBL] [Abstract][Full Text] [Related]
17. Prognostic Value of Preoperative Serum Levels of Five Tumor Markers (Carcinoembryonic Antigen, CA19-9, Alpha-fetoprotein, CA72-4, and CA125) in Gastric Cancer. Kim JH; Jun KH; Jung H; Park IS; Chin HM Hepatogastroenterology; 2014 May; 61(131):863-9. PubMed ID: 26176088 [TBL] [Abstract][Full Text] [Related]
18. Clinical usefulness of CEA, CA19-9, and CYFRA 21-1 as tumor markers for urothelial bladder carcinoma. Washino S; Hirai M; Matsuzaki A; Kobayashi Y Urol Int; 2011; 87(4):420-8. PubMed ID: 22041857 [TBL] [Abstract][Full Text] [Related]
19. The role of serum and gastric juice levels of carcinoembryonic antigen, CA19.9 and CA72.4 in patients with gastric cancer. Tocchi A; Costa G; Lepre L; Liotta G; Mazzoni G; Cianetti A; Vannini P J Cancer Res Clin Oncol; 1998; 124(8):450-5. PubMed ID: 9750022 [TBL] [Abstract][Full Text] [Related]
20. [Clinical value of serum CEA, CA19-9, CA72-4 and CA242 in the diagnosis and prognosis of gastric cancer]. Zhu YB; Ge SH; Zhang LH; Wang XH; Xing XF; DU H; Hu Y; Li YA; Jia YN; Lin Y; Fan B; Ji JF Zhonghua Wei Chang Wai Ke Za Zhi; 2012 Feb; 15(2):161-4. PubMed ID: 22368025 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]